Regeneron to offer prescriptions at most favored nation prices, Trump says
Tweet
Share
E-mail
FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Picture taken September 17, 2020. REUTERS/Brendan McDermid//File Photo
WASHINGTON, April 23 (Reuters) - U.S. President Donald Trump said on Thursday that Regeneron has agreed to offer prescriptions at most favored nation prices.
(Reporting by Trevor Hunnicutt; Writing by Jasper Ward in Washington; editing by Michelle Nichols)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
- JPM identifies consumer sectors to buy for a 2H rebound
- IBM shares pop following Trump’s praise at White House quantum summit
Create E-mail Alert Related Categories
General News, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
